Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Atypical Ductal Hyperplasia
Interventions: DEVICE: Contrast enhanced mammography
Sponsor: Dana-Farber Cancer Institute
Collaborators: GE Healthcare